LEMAITRE VASCULAR, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
LEMAITRE VASCULAR, INC. (LMAT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 27.86 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-02-26
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 27.86K shares, a 194.51% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 9.46K shares, a 51.05% decline from fiscal 2023.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 19.32K shares, a 59.81% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 12.09K shares, a 0.00% change from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month as first filed |
|---|---|---|
| 2025-12-31 | 27.86K shares 10-K · filed 2026-02-26 | |
| 2024-12-31 | 9.46K shares 10-K · filed 2026-02-26 | |
| 2023-12-31 | 19.32K shares 10-K · filed 2026-02-26 | |
| 2022-12-31 | 12.09K shares 10-K · filed 2025-02-28 | |
| 2021-12-31 | 12.09K shares 10-K · filed 2024-02-29 | 19.13K shares 10-K · filed 2022-02-28 |
| 2020-12-31 | 19.13K shares 10-K · filed 2024-02-29 | 5.41K shares 10-K · filed 2021-03-12 |
| 2019-12-31 | 101.17K shares 10-K · filed 2022-02-28 | |
| 2018-12-31 | 50.75K shares 10-K · filed 2019-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |